Pharmacological regulation of platelet factors that influence tumor angiogenesis

Seminars in Oncology

Volumn 41, Issue 3, 2014, Pages 370-377

  Yan, Mengjie ^a   Lesyk, Gabriela ^a   Radziwon Balicka, Aneta ^a   Jurasz, Paul ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOGENESIS INHIBITOR; ANGIOPOIETIN 1; ANTITHROMBOCYTIC AGENT; GELATINASE A; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; PLATELET DERIVED GROWTH FACTOR; THROMBOCYTE FACTOR; THROMBOCYTE FACTOR 4; TRANSFORMING GROWTH FACTOR BETA; VASCULOTROPIN;

ANGIOGENESIS; ANTIANGIOGENIC ACTIVITY; ANTIANGIOGENIC THERAPY; ARTICLE; CANCER CELL; CANCER PATIENT; HUMAN; METASTASIS; NEGATIVE FEEDBACK; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; THROMBOCYTE AGGREGATION; THROMBOCYTE COUNT; THROMBOCYTE RELEASE REACTION; TUMOR ANGIOGENESIS; TUMOR GROWTH;

ANGIOGENESIS INDUCING AGENTS; ANGIOGENESIS INHIBITORS; ANIMALS; BLOOD PLATELETS; HUMANS; NEOPLASMS; NEOVASCULARIZATION, PATHOLOGIC;

EID: 84904192972     PISSN: 00937754     EISSN: 15328708     Source Type: Journal    
DOI: 10.1053/j.seminoncol.2014.04.007     Document Type: Article

References (72)

1. Z.M. Ruggeri Platelets in atherothrombosis Nature Med 8 2002 1227 1234
2. A.D. Michelson Antiplatelet therapies for the treatment of cardiovascular disease Nat Rev Drug Discov 9 2010 154 169
3. J.N. Thon, and J.E. Italiano Platelets: production, morphology and ultrastructure Handb Exp Pharmacol 2012 3 22
4. D.L. Saussy Jr, D.E. Maise, D.A. Baron, S.H. Pepkowitz, and P.V. Halushka Subcellular localization of a thromboxane A2/prostaglandin H2 receptor antagonist binding site in human platelets Biochem Pharmacol 37 1988 647 654
5. G. Sawicki, E. Salas, J. Murat, H. Miszta-Lane, and M.W. Radomski Release of gelatinase A during platelet activation mediates aggregation Nature 386 1997 616 619
6. W.S. Choi, O.H. Jeon, H.H. Kim, and D.S. Kim MMP-2 regulates human platelet activation by interacting with integrin αIIbβ3 J Thromb Haemost 6 2008 517 523
7. M.W. Radomski, R. Palmer, and S. Moncada The anti-aggregating properties of vascular endothelium: interactions between prostacyclin and nitric oxide Br J Pharmacol 92 1987 639 646
8. M.W. Radomski, R.M. Palmer, and S. Moncada An L-arginine/nitric oxide pathway present in human platelets regulates aggregation Proc Natl Acad Sci U S A 87 1990 5193 5197
9. A. Radomski, P. Jurasz, E.J. Sanders, C.M. Overall, H.F. Bigg, and D.R. Edwards et al. Identification, regulation and role of tissue inhibitor of metalloproteinases-4 (TIMP-4) in human platelets Br J Pharmacol 137 2002 1330 1338
10. M.J. Santos-Martínez, C. Medina, P. Jurasz, and M.W. Radomski Role of metalloproteinases in platelet function Thromb Res 121 2008 535 542
11. D. Hanahan, and R.A. Weinberg Hallmarks of cancer: the next generation Cell 144 2011 646 674
12. A. Trousseau Clinique medicale de l'hotel-dieu Paris 1965 New Sydenham Society London, UK 94 96
13. T. Billroth Lectures on surgical pathology and therapeutics: a handbook for students and practitioners New Sydenham Society, London, UK 1878 355
14. G.J. Gasic, T.B. Gasic, and C.C. Stewart Antimetastatic effects associated with platelet reduction Proc Natl Acad Sci U S A 48 1968 1172 1178
15. P. Jurasz, D. Alonso-Escolano, and M.W. Radomski Platelet-cancer interactions: mechanisms and pharmacology of tumour cell-induced platelet aggregation Br J Pharmacol 143 2004 819 826
16. L. Erpenbeck, and M.P. Schon Deadly allies: the fatal interplay between platelets and metastasizing cancer cells Blood 115 2010 3427 3436
17. R.L. Stone, A.M. Nick, I.A. McNeish, F. Balkwill, H.D. Han, and J. Bottsford-Miller et al. Paraneoplastic thrombocytosis in ovarian cancer N Engl J Med 366 2012 610 618
18. P. Jurasz, S. North, P. Venner, and M.W. Radomski Matrix metalloproteinase-2 contributes to increased platelet reactivity in patients with metastatic prostate cancer: a preliminary study Thromb Res 112 2003 59 64
19. P. Jurasz, G. Sawicki, M. Duszyk, J. Sawicka, C. Miranda, and I. Mayers et al. Matrix metalloproteinase 2 in tumor cell-induced platelet aggregation: regulation by nitric oxide Cancer Res 61 2001 376 382
20. D. Alonso-Escolano, C. Medina, K. Cieslik, A. Radomski, P. Jurasz, and M.J. Santos-Martinez et al. Protein kinase C delta mediates platelet-induced breast cancer cell invasion J Pharmacol Exp Ther 318 2006 373 380
21. A. Radziwon-Balicka, M.J. Santos-Martinez, J.J. Corbalan, S. O'Sullivan, A. Treumann, and J.F. Gilmer et al. Mechanisms of platelet-stimulated colon cancer invasion: role of clusterin and thrombospondin 1 in regulation of the P38MAPK-MMP-9 pathway Carcinogenesis 35 2014 324 332
22. M. Labelle, S. Begum, and R.O. Hynes Direct signaling between platelets and cancer cells induces an epithelial-mesenchymal-like transition and promotes metastasis Cancer Cell 20 2011 576 590
23. A. Radziwon-Balicka, C. Medina, L. O'Driscoll, A. Treumann, D. Bazou, and I. Inkielewicz-Stepniak et al. Platelets increase survival of adenocarcinoma cells challenged with anticancer drugs: mechanisms and implications for chemoresistance Br J Pharmacol 167 2012 787 804
24. M.l. Demers, B. Ho-Tin-Noe, D. Schatzberg, J.J. Yang, and D.D. Wagner Increased efficacy of breast cancer chemotherapy in thrombocytopenic mice Cancer Res 71 2011 1540 1549
25. A. Radziwon-Balicka, C. Moncada de la Rosa, and P. Jurasz Platelet-associated angiogenesis regulating factors: a pharmacological perspective Can J Physiol Pharmacol 90 2012 679 688
26. D. Hanahan, and J. Folkman Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis Cell 86 1996 353 364
27. J. Folkman Tumor angiogenesis: therapeutic implications N Engl J Med 285 1971 1182 1186
28. P. Jurasz, D. Alonso, S. Castro-Blanco, F. Murad, and M.W. Radomski Generation and role of angiostatin in human platelets Blood 102 2003 3217 3223
29. A. Zamani, and Z. Qu Serotonin activates angiogenic phosphorylation signaling in human endothelial cells FEBS Lett 586 2012 2360 2365
30. S. Struyf, M.D. Burdick, P. Proost, J. Van Damme, and R.M. Strieter Platelets release CXCL4L1, a nonallelic variant of the chemokine platelet factor-4/CXCL4 and potent inhibitor of angiogenesis Circ Res 95 2004 855 857
31. A. Zaslavsky, K.-H. Baek, R.C. Lynch, S. Short, J. Grillo, and J. Folkman et al. Platelet-derived thrombospondin-1 (TSP-1) is a critical negative regulator and potential biomarker of angiogenesis Blood 115 2010 4605 4613
32. J.A. Coppinger, R. O'Connor, K. Wynne, M. Flanagan, M. Sullivan, and P.B. Maguire et al. Moderation of the platelet releasate response by aspirin Blood 109 2007 4786 4792
33. D. English, Z. Welch, A.T. Kovala, K. Harvey, O.V. Volpert, and D.N. Brindley et al. Sphingosine 1-phosphate released from platelets during clotting accounts for the potent endothelial cell chemotactic activity of blood serum and provides a novel link between hemostasis and angiogenesis FASEB J 14 2000 2255 2265
34. P. Jurasz, M.J. Santos-Martinez, A. Radomska, and M.W. Radomski Generation of platelet angiostatin mediated by urokinase plasminogen activator: effects on angiogenesis J Thromb Haemost 4 2006 1095 1106
35. T. Browder, J. Folkman, and S. Pirie-Shepherd The hemostatic system as a regulator of angiogenesis J Biol Chem 275 2000 1521 1524
36. D.R. Knighton, T.K. Hunt, K.K. Thakral, and W.H. Goodson 3rd Role of platelets and fibrin in the healing sequence: an in vivo study of angiogenesis and collagen synthesis Ann Surg 196 1982 379 388
37. P. Salven, A. Orpana, and H. Joensuu Leukocytes and platelets of patients with cancer contain high levels of vascular endothelial growth factor Clin Cancer Res 5 1999 487 491
38. R. Salgado, P.B. Vermeulen, I. Benoy, R. Weytjens, P. Huget, and E.V. Marck et al. Platelet number and interleukin-6 correlate with VEGF but not with bFGF serum levels of advanced cancer patients Br J Cancer 80 1999 892 897
39. G.J. Caine, G.Y. Lip, and A.D. Blann Platelet-derived VEGF, Flt-1, angiopoietin-1 and P-selectin in breast and prostate cancer: further evidence for a role of platelets in tumour angiogenesis Ann Med 36 2004 273 277
40. J. Peterson, D. Zurakowski, J. Italiano Jr., L. Michel, S. Connors, and M. Oenick et al. VEGF, PF4 and PDGF are elevated in platelets of colorectal cancer patients Angiogenesis 15 2012 265 273
41. H.M.W. Verheul, K. Hoekman, F. Lupu, H.J. Broxterman, P. van der Valk, and A.K. Kakkar et al. Platelet and coagulation activation with vascular endothelial growth factor generation in soft tissue sarcomas Clin Cancer Res 6 2000 166 171
42. R. Salgado, I. Benoy, J. Bogers, R. Weytjens, P. Vermeulen, and L. Dirix et al. Platelets and vascular endothelial growth factor (VEGF): a morphological and functional study Angiogenesis 4 2001 37 43
43. D.Y. Heng, W. Xie, M.M. Regan, M.A. Warren, A.R. Golshayan, and C. Sahi et al. Prognostic factors for overall survival in patients with metastatic renal cell carcinoma treated with vascular endothelial growth factor-targeted agents: results from a large, multicenter study J Clin Oncol 27 2009 5794 5799
44. W. Feng, M. Madajka, B.A. Kerr, G.H. Mahabeleshwar, S.W. Whiteheart, and T.V. Byzova A novel role for platelet secretion in angiogenesis: mediating bone marrow-derived cell mobilization and homing Blood 117 2011 3893 3902
45. D. Cervi, T.-T. Yip, N. Bhattacharya, V.N. Podust, J. Peterson, and A. Abou-Slaybi et al. Platelet-associated PF-4 as a biomarker of early tumor growth Blood 111 2008 1201 1207
46. G.L. Klement, T.-T. Yip, F. Cassiola, L. Kikuchi, D. Cervi, and V. Podust et al. Platelets actively sequester angiogenesis regulators Blood 113 2009 2835 2842
47. G. Pietramaggiori, S.S. Scherer, D. Cervi, G. Klement, and D.P. Orgill Tumors stimulate platelet delivery of angiogenic factors in vivo: an unexpected benefit Am J Pathol 173 2008 1609 1616
48. J. Kisucka, C.E. Butterfield, D.G. Duda, S.C. Eichenberger, S. Saffaripour, and J. Ware et al. Platelets and platelet adhesion support angiogenesis while preventing excessive hemorrhage Proc Natl Acad Sci U S A 103 2006 855 860
49. R. Li, M. Ren, N. Chen, M. Luo, X. Deng, and J. Xia et al. Presence of intratumoral platelets is associated with tumor vessel structure and metastasis BMC Cancer 14 2014 167
50. B. Ho-Tin-Noe, T. Goerge, S.M. Cifuni, D. Duerschmied, and D.D. Wagner Platelet granule secretion continuously prevents intratumor hemorrhage Cancer Res 68 2008 6851 6858
51. H.S. Kuznetsov, T. Marsh, B.A. Markens, Z. Castano, A. Greene-Colozzi, and S.A. Hay et al. Identification of luminal breast cancers that establish a tumor-supportive macroenvironment defined by proangiogenic platelets and bone marrow-derived cells Cancer Discov 2 2012 1150 1165
52. J.E. Italiano Jr, J.L. Richardson, S. Patel-Hett, E. Battinelli, A. Zaslavsky, and S. Short et al. Angiogenesis is regulated by a novel mechanism: pro- and antiangiogenic proteins are organized into separate platelet alpha-granules and differentially released Blood 111 2008 1227 1233
53. L. Ma, R. Perini, W. McKnight, M. Dicay, A. Klein, and M.D. Hollenberg et al. Proteinase-activated receptors 1 and 4 counter-regulate endostatin and VEGF release from human platelets Proc Natl Acad Sci U S A 102 2005 216 220
54. J. Kamykowski, P. Carlton, S. Sehgal, and B. Storrie Quantitative immunofluorescence mapping reveals little functional co-clustering of proteins within platelet α-granules Blood 118 2011 1370 1373
55. D. Jonnalagadda, L.T. Izu, and S.W. Whiteheart Platelet secretion is kinetically heterogeneous in an agonist-responsive manner Blood 120 2012 5209 5216
56. E.M. Battinelli, B.A. Markens, and J.E. Italiano Release of angiogenesis regulatory proteins from platelet alpha granules: modulation of physiologic and pathologic angiogenesis Blood 118 2011 1359 1369
57. A. Radziwon-Balicka, C. Moncada de la Rosa, B. Zielnik, A. Doroszko, and P. Jurasz Temporal and pharmacological characterization of angiostatin release and generation by human platelets: implications for endothelial cell migration PLoS ONE 8 2013 e59281
58. L. Ma, S.N. Elliott, G. Cirino, A. Buret, L.J. Ignarro, and J.L. Wallace Platelets modulate gastric ulcer healing: Role of endostatin and vascular endothelial growth factor release Proc Natl Acad Sci U S A 98 2001 6470 6475
59. J. Etulain, C. Fondevila, S. Negrotto, and M. Schattner Platelet-mediated angiogenesis is independent of VEGF and fully inhibited by aspirin Br J Pharmacol 170 2013 255 265
60. P.M. Rothwell, J.F. Price, F.G.R. Fowkes, A. Zanchetti, M.C. Roncaglioni, and G. Tognoni et al. Short-term effects of daily aspirin on cancer incidence, mortality, and non-vascular death: analysis of the time course of risks and benefits in 51 randomised controlled trials Lancet 379 2012 1602 1612
61. P.M. Rothwell, M. Wilson, J.F. Price, J.F.F. Belch, T.W. Meade, and Z. Mehta Effect of daily aspirin on risk of cancer metastasis: a study of incident cancers during randomised controlled trials Lancet 379 2012 1591 1601
62. N.M. Bambace, J.E. Levis, and C.E. Holmes The effect of P2Y-mediated platelet activation on the release of VEGF and endostatin from platelets Platelets 21 2010 85 93
63. S.D. Wiviott, E. Braunwald, C.H. McCabe, G. Montalescot, W. Ruzyllo, and S. Gottlieb et al. Prasugrel versus Clopidogrel in patients with acute coronary syndromes N Engl J Med 357 2007 2001 2015
64. A. Amirkhosravi, M. Amaya, F. Siddiqui, J.P. Biggerstaff, T.V. Meyer, and J.L. Francis Blockade of GpIIb/IIIa inhibits the release of vascular endothelial growth factor (VEGF) from tumor cell-activated platelets and experimental metastasis Platelets 10 1999 285 292
65. M. Trikha, Z. Zhou, J. Timar, E. Raso, M. Kennel, and E. Emmell et al. Multiple roles for platelet GPIIb/IIIa and alphavbeta3 integrins in tumor growth, angiogenesis, and metastasis Cancer Res 62 2002 2824 2833
66. S. Vadhan-Raj Management of chemotherapy-induced thrombocytopenia: current status of thrombopoietic agents Semin Hematol 46 2009 S26 S32
67. 2+-induced alpha - and dense-core granule secretion in platelets J Biol Chem 276 2001 39379 39385
68. O. Konopatskaya, K. Gilio, M.T. Harper, Y. Zhao, J.M. Cosemans, and Z.A. Karim et al. PKCα regulates platelet granule secretion and thrombus formation in mice J Clin Invest 119 2009 399 407
69. C. Moncada de la Rosa, A. Radziwon-Balicka, H. El-Sikhry, J. Seubert, P.P. Ruvolo, and M.W. Radomski et al. Pharmacological PKCα inhibition uncouples human platelet-stimulated angiogenesis from collagen-induced aggregation J Pharmacol Exp Ther 345 2013 15 24
70. H.M. Verheul, K. Hoekman, S. Luykx-de Bakker, C.A. Eekman, C.C. Folman, and H.J. Broxterman et al. Platelet: transporter of vascular endothelial growth factor Clin Cancer Res 3 1997 2187 2190
71. E.M. Battinelli, B.A. Markens, R.A. Kulenthirarajan, K.R. Machlus, R. Flaumenhaft, and J.E. Italiano Anticoagulation inhibits tumor cell mediated release of platelet angiogenic proteins and diminishes platelet angiogenic response Blood 123 2014 101 112
72. M. Dovizio, S. Tacconelli, E. Ricciotti, A. Bruno, T. Maier Jr, and P. Anzellotti et al. Effects of celecoxib on prostanoid biosynthesis and circulating angiogenesis proteins in familial adenomatous polyposis J Pharmacol Exp Therap 341 2012 242 250